Advance in phytoestrogenic effects of psoralen

doi:10.3969/j.issn.1674-8115.2019.02.018

›› 2019, Vol. 39 ›› Issue (2): 203-.doi: 10.3969/j.issn.1674-8115.2019.02.018

• Review • Previous Articles Next Articles

Advance in phytoestrogenic effects of psoralen

LI Hu-xiao, SONG Zhong-chen

Department of Periodontology, Shanghai Ninth Peoples Hospital, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China

Online:2019-02-28 Published:2019-03-19
Supported by:
National Key Research and Development Program of China, 2017YFC0840100, 2017YFC0840110)。

Abstract

Abstract: Psoralen is one of the effective ingredients extracted Chinese herbal medicine Psoralea corylifolia. Studies have found that psoralen has an estrogenic effect and can regulate the estrogen receptor. Psoralen can exert phytoestrogenic effects such as anti-tumor, anti-osteoporosis, anti-oxidation and protection of cardiovascular. This article reviewed the research progress of phytoestrogenic effects of psoralen.

Key words: psoralen, estrogen, phytoestrogens, estrogen receptor

CLC Number:

R961.1

LI Hu-xiao, SONG Zhong-chen. Advance in phytoestrogenic effects of psoralen[J]. , 2019, 39(2): 203-.

[1]	LIU Weiwei, WANG Long. Research progress in the correlation and treatment of menopause and non-alcoholic fatty liver disease in women [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 125-131.
[2]	Qian ZHUANG, Zhi-xia DONG, Xin-jian WAN. Research progress of effect of estrogen and its receptors on cholesterol gallstone disease [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1394-1396.
[3]	HE Qin, ZHANG Wei-bin, SHEN Yu-hui. Establishment of a prognostic scoring model for the breast cancer patients with spinal metastasis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(9): 1243-1248.
[4]	LU Yu-jie, JIN Ze-yu, LI Ya-fen, SHEN Kun-wei, CHEN Wei-guo, CHEN Xiao-song. Receptor status testing and its influence on following treatment selection in breast cancer patients with loco-regional recurrence [J]. , 2019, 39(9): 1071-.
[5]	ZHAO Jing-yu, HUANG Ming-jian, ZHANG Xiao-ling. Effects of estrogen on proliferation, apoptosis and differentiation of bone marrow macrophage [J]. , 2018, 38(7): 745-.
[6]	LI Xiao-tian1, 2, ZHOU Wei2, SONG Zhong-chen1, 2. Anti-inflammation effects of psoralen and angelicin on human periodontal ligament cells in vitro [J]. , 2018, 38(2): 128-.
[7]	WANG Zhi, SONG Xiao-xing, ZHANG Fu-jun . Inflammatory mechanism of estrogen in the pain modulation of ovariectomized mice#br# [J]. , 2017, 37(7): 936-.
[8]	FU Chao, LI Yong, LI Li-feng, XIAO Ting-ting, MA Xiang-yu, ZHANG Bi . Effects of the estrogen deficiency on Notch signaling pathway in osteoarthritis [J]. , 2017, 37(4): 467-.
[9]	KANG Le, CHEN Li, LI Cai-xia, CHEN Xia, CHENG Zhong-ping. Differential expression of estrogen receptor GPR30 in main supporting ligaments of patients with pelvic organ prolapsed#br# [J]. , 2017, 37(10): 1376-.
[10]	YUAN Jiang-jing, ZHAO Wei-hong, ZHANG Duo, HE Xiao-ying, ZHANG Jian. Effect of mifepristone on ciliary beat frequency and estrogen and progesterone receptor expression levels in human fallopian tubes [J]. , 2017, 37(10): 1402-.
[11]	HU Yan, GAO Yan-hong. Research progress of bone-targeting estrogen-like drugs in treatment of osteoporosis [J]. , 2016, 36(3): 437-.
[12]	WANG Cheng, HONG Yan, YU Yan-min, et al. Correlation between metastasis-associated protein 3 and prognosis of patients with breast cancer [J]. , 2016, 36(2): 195-.
[13]	KANG Jun-jun, QIU Jian-yin, TAO Jing, ZHANG Lan. Analysis of the association between estrogen receptor β gene and depressive disorder of perimenopausal patients [J]. , 2015, 35(10): 1521-.
[14]	OUYANG Yi-qin, YANG Min, LI Li, et al. Relationship between expression of estrogen receptor α isoforms in endometrial cancer and its prognosis [J]. , 2014, 34(3): 338-.
[15]	WANG Jie, Haji Akber AISA, MA Hai-rong, et al. GPER: a novel target in treatment of estrogen-related diseases [J]. , 2013, 33(2): 225-.

Advance in phytoestrogenic effects of psoralen

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

TrendMD

References

Related Articles 15

Recommended Articles

Metrics

Comments